These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

596 related items for PubMed ID: 9469432

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.
    Fallarino F, Uyttenhove C, Boon T, Gajewski TF.
    J Immunol; 1996 Feb 01; 156(3):1095-100. PubMed ID: 8557984
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Oral administration of xanthan gum enhances antitumor activity through Toll-like receptor 4.
    Takeuchi A, Kamiryou Y, Yamada H, Eto M, Shibata K, Haruna K, Naito S, Yoshikai Y.
    Int Immunopharmacol; 2009 Dec 01; 9(13-14):1562-7. PubMed ID: 19788935
    [Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. Immunoregulatory role of IL-10 during superantigen-induced hyporesponsiveness in vivo.
    Sundstedt A, Höiden I, Rosendahl A, Kalland T, van Rooijen N, Dohlsten M.
    J Immunol; 1997 Jan 01; 158(1):180-6. PubMed ID: 8977189
    [Abstract] [Full Text] [Related]

  • 69. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
    Sobotková E, Nouza K.
    Neoplasma; 1993 Jan 01; 40(2):75-80. PubMed ID: 8350958
    [Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12.
    Kaiga T, Sato M, Kaneda H, Iwakura Y, Takayama T, Tahara H.
    J Immunol; 2007 Jun 15; 178(12):7571-80. PubMed ID: 17548592
    [Abstract] [Full Text] [Related]

  • 76. In vivo requirement for asialo GM1 and Thy1 positive leukocytes for antitumor effect of rIL-2 +/- rIFN-gamma.
    Silagi S, Dutkowski R, Schaefer A.
    Anticancer Res; 1988 Jun 15; 8(6):1265-9. PubMed ID: 2905882
    [Abstract] [Full Text] [Related]

  • 77. Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases.
    Kaido TJ, Maury C, Gresser I.
    Cancer Res; 1995 Dec 15; 55(24):6133-9. PubMed ID: 8521404
    [Abstract] [Full Text] [Related]

  • 78. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer.
    Tahara H, Lotze MT.
    Gene Ther; 1995 Mar 15; 2(2):96-106. PubMed ID: 7719935
    [Abstract] [Full Text] [Related]

  • 79. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
    Gabriele L, Proietti E, Greco G, Venditti M, Gresser I, Schirrmacher V, Von Hoegen P, Testa U, Modesti A, Cianfriglia M.
    Invasion Metastasis; 1993 Mar 15; 13(3):147-62. PubMed ID: 8112975
    [Abstract] [Full Text] [Related]

  • 80. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
    Voronov E, Reich E, Dotan S, Dransh P, Cohen I, Huszar M, Fogel M, Kleinman HK, White RM, Apte RN.
    J Immunotoxicol; 2010 Mar 15; 7(1):27-38. PubMed ID: 20001788
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.